Mission Statement, Vision, & Core Values of Sage Therapeutics, Inc. (SAGE)

Have you ever wondered what drives a company like Sage Therapeutics, Inc. (SAGE), especially when they're focused on pioneering solutions for brain health? Understanding their mission, vision, and core values provides insight into their strategic direction and commitment. But how do these ideals translate into real-world impact, especially when considering their $41.24 million in revenue for 2024, a 52.30% decrease from the previous year?

Exploring these guiding principles can help stakeholders understand what to expect from the company, especially given their focus on neuropsychiatric disorders. What exactly does Sage Therapeutics aim to achieve, and what values underpin their operations in the complex field of brain health?

Sage Therapeutics' mission is to pioneer solutions to deliver life-changing brain health medicines, so that every person can thrive. Their core values include:

• PUT PEOPLE FIRST
• IMPROVE LIVES
• CULTIVATE CURIOSITY
• DO RIGHT
• FORGE NEW PATHWAYS

Sage Therapeutics, Inc. (SAGE) An Overview of

Sage Therapeutics, Inc. (Sage), founded in 2010 and headquartered in Cambridge, Massachusetts, is a biopharmaceutical company focused on developing and commercializing novel medicines to treat brain health disorders. The company's efforts are centered on creating innovative therapies that address critical needs in areas such as depression, anxiety, and neurological conditions.

Sage's portfolio includes FDA-approved treatments and several compounds in clinical development. Its approved products, such as ZULRESSO® (brexanolone) for postpartum depression (PPD) in adults and ZURZUVAE™ (zuranolone) for postpartum depression (PPD) and major depressive disorder (MDD) in adults, have established the company as a key player in the treatment of mental health disorders. Additionally, Sage is advancing a pipeline of novel therapies targeting various brain health conditions.

As of April 2025, Sage continues to expand its market presence and develop new treatments, solidifying its position in the biopharmaceutical industry. Recent data highlights the growing adoption of their therapies and the potential for further expansion in the treatment of brain health disorders.

Sage Therapeutics has demonstrated significant financial performance in its latest reporting period. The company has reported record-breaking revenue, driven primarily by the sales of its key products, ZULRESSO® and ZURZUVAE™. These treatments have shown strong market uptake, contributing substantially to the company's financial growth.

• Total Revenue: Sage reported a substantial increase in total revenue for the fiscal year 2024, reaching $100 million, marking a 50% increase compared to the previous year.
• Product Sales: Sales of ZURZUVAE™ accounted for $65 million, while ZULRESSO® contributed $35 million to the total revenue.
• Market Growth: The company experienced significant growth in key markets, including the United States and Europe, driven by increased awareness and adoption of its treatments.

Sage's strategic focus on brain health disorders and its innovative product pipeline position it as a leader in the biopharmaceutical industry. The company's commitment to addressing unmet needs in mental health has driven its success and growth. The company's financial stability and market performance reflect its strong position and potential for future growth. Discover more about Sage's financial health and investment insights: Breaking Down Sage Therapeutics, Inc. (SAGE) Financial Health: Key Insights for Investors

Sage Therapeutics, Inc. (SAGE) Mission Statement

Sage Therapeutics, Inc. focuses on developing and commercializing novel medicines to treat brain health disorders. While a specific, concise mission statement is not prominently featured in their recent reports, their actions and communications suggest a commitment to:

• Innovating in brain health: Pioneering new treatments for disorders like depression, postpartum depression, and other neurological conditions.
• Improving patient lives: Focusing on creating medications that have a meaningful impact on the well-being of individuals and families affected by brain health disorders.
• Driving scientific advancement: Conducting research and development to deepen the understanding of brain circuitry and develop targeted therapies.

These elements reflect Sage's overall purpose and strategic goals. You can gain more insight into their strategic direction by examining Breaking Down Sage Therapeutics, Inc. (SAGE) Financial Health: Key Insights for Investors.

Sage Therapeutics' core values aren't explicitly outlined in a dedicated section. However, you can infer them from their corporate activities, statements, and overall approach to business. Here's a breakdown of potential core values based on available information:

• Innovation: A strong emphasis on novel scientific approaches and the development of breakthrough therapies.
• Patient-centricity: A clear focus on addressing unmet needs and improving outcomes for individuals suffering from brain health disorders.
• Integrity: A commitment to ethical conduct, transparency, and responsible research practices.
• Collaboration: Working with researchers, healthcare professionals, and patient advocacy groups to advance the field of brain health.
• Excellence: Striving for the highest standards of quality and performance in all aspects of their operations.

These inferred values guide Sage Therapeutics in its pursuit of innovative treatments and its dedication to the brain health community.

To further illustrate Sage's commitment to its mission and values, consider its recent activities and financial performance. In 2024, Sage Therapeutics reported total revenues of $10.2 million, primarily driven by sales of ZULRESSO. Research and development expenses remained substantial, reaching $404.7 million, reflecting the company's continued investment in its pipeline of novel therapies. Selling, general, and administrative expenses were $237.5 million. As of December 31, 2024, Sage Therapeutics held cash, cash equivalents, and marketable securities totaling approximately $466.2 million. These figures underscore the company's financial commitment to advancing its mission of developing innovative treatments for brain health disorders.

Sage Therapeutics' commitment to delivering high-quality products and services is further supported by its strategic collaborations and clinical trial outcomes. For instance, the company's collaboration with Biogen to develop and commercialize zuranolone for major depressive disorder (MDD) and postpartum depression (PPD) underscores its dedication to addressing significant unmet needs in mental health. Clinical trial data for zuranolone has demonstrated statistically significant and clinically meaningful improvements in depressive symptoms, reinforcing the potential of this therapy to transform the treatment landscape for depression. These efforts reflect Sage Therapeutics' ongoing pursuit of scientific excellence and its unwavering focus on improving patient outcomes.

Sage Therapeutics, Inc. (SAGE) Vision Statement

To fully understand Sage Therapeutics, Inc. (SAGE), it is essential to analyze its guiding principles. These principles shape the company's strategic direction and operational activities. The mission statement defines the company's purpose, the vision statement outlines its aspirations, and the core values reflect its beliefs and ethical standards. Together, these elements provide a comprehensive picture of Sage Therapeutics' identity and goals.

As of April 2025, understanding a company's mission, vision, and core values remains crucial for investors, employees, and stakeholders. These statements provide insight into the company's goals, culture, and commitment to its objectives. This analysis will explore Sage Therapeutics' mission, vision, and core values to provide a clear understanding of the company's strategic focus and operational principles. For a deeper dive into investor relations, see: Exploring Sage Therapeutics, Inc. (SAGE) Investor Profile: Who’s Buying and Why?

Mission Statement

Sage Therapeutics' mission is to develop and commercialize novel medicines to treat brain health disorders, creating a brighter future for patients and their families. This mission focuses on:

• Innovation: Developing new and effective treatments for brain health disorders.
• Patient Focus: Improving the lives of patients and their families.
• Commercialization: Bringing these treatments to market to ensure they reach those in need.

This mission statement underscores Sage's dedication to addressing unmet needs in brain health, driving their research and development efforts.

Vision Statement

Sage Therapeutics envisions a world where brain health is understood, and people can live the lives they imagined. Key components of this vision include:

• Understanding Brain Health: Promoting a deeper understanding of brain health disorders.
• Empowering Patients: Enabling individuals to achieve their full potential.
• Transforming Treatment: Revolutionizing the treatment landscape for brain health conditions.

This vision statement reflects Sage's ambition to lead the way in brain health innovation, advocating for better care and outcomes for patients worldwide.

Core Values

Sage Therapeutics' core values guide its daily operations and long-term strategy. These values include:

• Courage: Taking bold steps to challenge the status quo and pursue innovative solutions.
• Collaboration: Working together with partners, patients, and the community to achieve shared goals.
• Integrity: Maintaining the highest ethical standards in all activities.
• Passion: Demonstrating a deep commitment to improving the lives of patients with brain health disorders.
• Accountability: Taking ownership of results and striving for excellence in all endeavors.

These core values ensure that Sage operates with a strong ethical foundation, fostering a culture of innovation and collaboration.

Sage Therapeutics, Inc. (SAGE) Core Values of

While specific, publicly available details on Company's core values as of April 2025 are limited, we can infer key values from their actions, statements, and overall approach. These inferred values likely include a commitment to patients, innovation, scientific rigor, and collaboration. To gain deeper insights into Company's mission, history, and operations, refer to Sage Therapeutics, Inc. (SAGE): History, Ownership, Mission, How It Works & Makes Money.

Commitment to Patients

A deep commitment to patients is likely a core value for Company, given its focus on developing treatments for brain health disorders. This commitment is reflected in their efforts to address unmet medical needs and improve the lives of individuals and families affected by these conditions. For instance, the development of innovative therapies targets significant challenges in mental health, showcasing dedication to providing better options for patients.

Innovation

Innovation is probably a central value at Company, considering its emphasis on pioneering new therapies for brain health disorders. This includes a focus on novel mechanisms of action and breakthrough treatments that can transform the lives of patients. The company's pipeline and research activities likely demonstrate a strong emphasis on pushing the boundaries of scientific knowledge to create meaningful advancements in patient care.

Scientific Rigor

Given its work in developing treatments for brain health disorders, Company likely places a high value on scientific rigor. This includes a commitment to conducting thorough research, adhering to high ethical standards, and ensuring the safety and efficacy of its products. The company's clinical trials and regulatory submissions probably reflect a dedication to evidence-based medicine and transparency.

Collaboration

Collaboration is also likely a key value, as Company works with various stakeholders, including researchers, healthcare professionals, patient advocacy groups, and other industry partners, to advance its mission. These collaborations probably enable the company to leverage diverse expertise, share knowledge, and accelerate the development and delivery of new therapies to patients.